Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
HSA · 11 medicines
AEMPS · 10 medicines
AIFA · 10 medicines
SFDA · 10 medicines · Historical list
PHARMAC · 9 medicines
MS · 8 medicines · Historical list
ALIMS · 8 medicines
EMA · 7 medicines
HALMED · 7 medicines
CBG-MEB · 7 medicines
FDA · 7 medicines
TFDA · 4 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
163 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Doxorubicin | Canada | 2 MG / ML | Solution | Marketed | Pfizer Canada Ulc |
| Doxorubicina Teva | Italy | Concentrato per soluzione per infusione | Authorised | Teva Italia S.R.L. | |
| Doxorubicin Hydrochloride | United States | 10MG/VIAL, 150MG/75ML, 150MG/VIAL … | injectable | Marketed | Sagent Pharms |
| Doxorubicin Hydrochloride | United States | 20MG/10ML, 50MG/25ML | injectable, liposomal | Marketed | Qilu Pharm Hainan |
| Doxorubicina Hikma | Italy | Concentrato per soluzione per infusione | Authorised | Hikma Farmaceutica (Portugal) S.A. | |
| Doxorubicin Ebewe® | Serbia | 10mg/5mL | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Sandoz Pharmaceuticals D.D. Beograd |
| Doxorubicin Ebewe® | Serbia | 50mg/25 mL | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Sandoz Pharmaceuticals D.D. Beograd |
| Doxorubicin Ebewe | New Zealand | Inj 2 mg per ml, 100 ml vial | Funded | ||
| Doxorubicin Ebewe | New Zealand | Inj 2 mg per ml, 100 ml vial | Funded | ||
| Doxorubicin Ebewe | New Zealand | Inj 2 mg per ml, 5 ml vial | Funded | ||
| Doxorubicin Ebewe | New Zealand | Inj 2 mg per ml, 25 ml vial | Funded | ||
| Doxorubicina Aurobindo | Italy | Concentrato per soluzione per infusione | Authorised | Eugia Pharma (Malta) Limited | |
| Doxorubicin Hydrochloride (Liposomal) | United States | 20MG/10ML, 50MG/25ML | injectable, liposomal | Marketed | Alembic |
| Doxorubicin Injection, BP | Canada | 2 MG / ML | Solution | Marketed | Accord Healthcare INC |
| Doxorubicin Hydrochloride Injection | Canada | 2 MG / ML | Solution | Marketed | Teva Canada Limited |
| Doxorubicina Accord Healthcare Italia | Italy | Concentrato per soluzione per infusione | Authorised | Accord Healthcare, S.L.U. | |
| Doxorubicin SUN | European Union | Refused | Sun Pharmaceutical Industries Europe B.V. | ||
| Doxorubicina Liposomiale Pegilata DR. Reddy'S | Italy | Concentrato per dispersione per infusione | Authorised | DR. Reddy'S S.R.L. | |
| Doxorubicin Hydrochloride Injection | Canada | 2 MG / ML | Solution | Authorised | Omega Laboratories Limited |
| Doxorubicin Hydrochloride for Injection USP | Canada | 150 MG / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Doxorubicin Hydrochloride for Injection USP | Canada | 50 MG / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Doxorubicina Accord 2 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 2 mg | concentrado para solución para perfusión | Marketed | Accord Healthcare S.L.U. |
| DOXORUBICINA AUROVITAS 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | Spain | 2,00 mg | concentrado para solución para perfusión | Marketed | Eugia Pharma (Malta) Limited |
| Doxorubicin Pliva 2 mg/ml otopina za injekciju/infuziju | Croatia | otopina za injekciju/infuziju | Marketed | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb | |
| Doxorubicine Accord 2 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Accord Healthcare B.V. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
Guidelines in the library that name this substance.
Recent articles that name this substance.
